Genetic Epidemiology, Psychiatric Genetics, Asthma Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
26595473
TITLE
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
ABSTRACT
Despite evidence for heritable variation in cannabis involvement and the discovery of cannabinoid receptors and their endogenous ligands, no consistent patterns have emerged from candidate endocannabinoid (eCB) genetic association studies of cannabis involvement. Given interactions between eCB and stress systems and associations between childhood stress and cannabis involvement, it may be important to consider childhood adversity in the context of eCB-related genetic variation. We employed a system-level gene-based analysis of data from the Comorbidity and Trauma Study (N = 1,558) to examine whether genetic variation in six eCB genes (anabolism: DAGLA, DAGLB, NAPEPLD; catabolism: MGLL, FAAH; binding: CNR1; SNPs N = 65) and childhood sexual abuse (CSA) predict cannabis dependence symptoms. Significant interactions with CSA emerged for MGLL at the gene level (p = .009), and for rs604300 within MGLL (ΔR2 = .007, p < .001), the latter of which survived SNP-level Bonferroni correction and was significant in an additional sample with similar directional effects (N = 859; ΔR2 = .005, p = .026). Furthermore, in a third sample (N = 312), there was evidence that rs604300 genotype interacts with early life adversity to predict threat-related basolateral amygdala habituation, a neural phenotype linked to the eCB system and addiction (ΔR2 = .013, p = .047). Rs604300 may be related to epigenetic modulation of MGLL expression. These results are consistent with rodent models implicating 2-arachidonoylglycerol (2-AG), an endogenous cannabinoid metabolized by the enzyme encoded by MGLL, in the etiology of stress adaptation related to cannabis dependence, but require further replication.
(c) 2015 APA, all rights reserved).
DATE PUBLISHED
2015 Nov
HISTORY
PUBSTATUS PUBSTATUSDATE
entrez 2015/11/24 06:00
pubmed 2015/11/26 06:00
medline 2015/11/26 06:00
pmc-release 2016/11/01 00:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Carey CE Carey Caitlin E CE Department of Psychology, Washington University in St. Louis.
Agrawal A Agrawal Arpana A Department of Psychiatry, Washington University in St. Louis.
Zhang B Zhang Bo B Department of Genetics, Washington University in St. Louis.
Conley ED Conley Emily D ED 23andMe.
Degenhardt L Degenhardt Louisa L National Drug and Alcohol Research Centre, University of New South Wales.
Heath AC Heath Andrew C AC Department of Psychiatry, Washington University in St. Louis.
Li D Li Daofeng D Department of Genetics, Washington University in St. Louis.
Lynskey MT Lynskey Michael T MT Institute of Psychiatry, Kings College London.
Martin NG Martin Nicholas G NG Berghofer Medical Research Institute.
Montgomery GW Montgomery Grant W GW Berghofer Medical Research Institute.
Wang T Wang Ting T Department of Genetics, Washington University in St. Louis.
Bierut LJ Bierut Laura J LJ Department of Psychiatry, Washington University in St. Louis.
Hariri AR Hariri Ahmad R AR Department of Psychology and Neuroscience, Duke University.
Nelson EC Nelson Elliot C EC Department of Psychiatry, Washington University in St. Louis.
Bogdan R Bogdan Ryan R Department of Psychology, Washington University in St. Louis.
INVESTIGATORS
JOURNAL
VOLUME: 124
ISSUE: 4
TITLE: Journal of abnormal psychology
ISOABBREVIATION: J Abnorm Psychol
YEAR: 2015
MONTH: Nov
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1939-1846
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: J Abnorm Psychol
COUNTRY: United States
ISSNLINKING: 0021-843X
NLMUNIQUEID: 0034461
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):1-15 19285257
Cites Psychopharmacology (Berl). 2009 Apr;203(3):511-7 19002671
Cites Addiction. 2009 Apr;104(4):518-32 19335651
Cites Learn Mem. 2009 May;16(5):279-88 19380710
Cites AAPS J. 2009 Jun;11(2):342-52 19430909
Cites Lancet. 2010 Aug 14;376(9740):489-90 20709215
Cites Lancet. 2010 Aug 14;376(9740):517-23 20709233
Cites Genet Epidemiol. 2010 Sep;34(6):591-602 20718045
Cites Int J Biochem Cell Biol. 2010 Nov;42(11):1788-801 20541029
Cites Adv Genet. 2010;72:141-79 21029852
Cites J Neurosci. 2010 Nov 10;30(45):14980-6 21068301
Cites Addict Behav. 2011 Jan-Feb;36(1-2):27-36 20833480
Cites Nat Methods. 2011 Dec;8(12):989-90 22127213
Cites Transl Psychiatry. 2011;1:e44 22833190
Cites J Neurosci. 2008 Mar 5;28(10):2313-9 18322078
Cites Drug Alcohol Depend. 2008 May 1;95(1-2):14-22 18243582
Cites J Neuroendocrinol. 2008 May;20 Suppl 1:1-9 18426492
Cites Br J Pharmacol. 2008 May;154(2):369-83 18414385
Cites Addiction. 2008 Jun;103(6):990-7 18482422
Cites Depress Anxiety. 2001;13(4):179-83 11413564
Cites J Trauma Stress. 2001 Oct;14(4):843-57 11776429
Cites Curr Opin Pharmacol. 2002 Feb;2(1):50-5 11786308
Cites Clin Psychol Rev. 2002 Feb;22(1):27-77 11793578
Cites Science. 2002 Apr 26;296(5568):678-82 11976437
Cites J Neurosci. 2002 May 1;22(9):3326-31 11978807
Cites Child Abuse Negl. 2003 Feb;27(2):169-90 12615092
Cites Science. 2003 Jul 18;301(5631):386-9 12869766
Cites Nat Rev Neurosci. 2003 Nov;4(11):873-84 14595399
Cites Am J Hum Genet. 2004 Sep;75(3):353-62 15272419
Cites J Stud Alcohol. 1994 Mar;55(2):149-58 8189735
Cites J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1365-74 8885591
Cites Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):7-12 9164547
Cites Am J Med Genet. 1998 May 8;81(3):207-15 9603606
Cites J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 9881538
Cites Pharmacol Res. 2009 Aug;60(2):77-84 19559360
Cites Behav Res Methods. 2009 Aug;41(3):924-36 19587209
Cites Nat Rev Genet. 2010 Dec;11(12):843-54 21085203
Cites Addict Biol. 2011 Jan;16(1):1-6 20192949
Cites Nat Neurosci. 2011 Jan;14(1):9-15 21187849
Cites Pharmacol Biochem Behav. 2011 Mar;98(1):21-7 21145341
Cites Pharmacol Ther. 2011 Mar;129(3):307-20 21055418
Cites J Anxiety Disord. 2011 Apr;25(3):437-43 21146357
Cites Am J Hum Genet. 2011 Mar 11;88(3):283-93 21397060
Cites Brain Res. 2011 May 16;1390:80-9 21419109
Cites Arch Gen Psychiatry. 2011 May;68(5):444-54 21199959
Cites Drug Alcohol Depend. 2011 May 1;115(1-2):120-30 21145178
Cites Am J Hum Genet. 2007 Dec;81(6):1278-83 17966091
Cites Addict Biol. 2011 Jul;16(3):514-8 21668797
Cites Neuropsychopharmacology. 2011 Aug;36(9):1940-7 21593733
Cites Biol Psychiatry. 2011 Sep 1;70(5):479-86 21684528
Cites Biol Psychiatry. 2011 Sep 15;70(6):513-8 21529783
Cites J Pharmacol Exp Ther. 2011 Oct;339(1):173-85 21719468
Cites Am J Psychiatry. 2011 Oct;168(10):1041-9 21890791
Cites Addict Behav. 2012 Jan;37(1):53-9 21958588
Cites Neuropsychopharmacology. 2011 Dec;36(13):2750-61 21849983
Cites Endocrinology. 2004 Dec;145(12):5431-8 15331569
Cites Pharmacol Biochem Behav. 2005 Jun;81(2):331-42 15927244
Cites Pharmacol Biochem Behav. 2005 Jun;81(2):224-38 15935454
Cites Emotion. 2005 Dec;5(4):396-407 16366744
Cites Psychoneuroendocrinology. 2006 May;31(4):526-36 16442741
Cites Hum Genomics. 2006 Mar;2(5):310-7 16595075
Cites Nat Rev Neurosci. 2006 Jul;7(7):583-90 16791147
Cites Psychol Med. 2006 Oct;36(10):1473-83 16854248
Cites Psychol Med. 2006 Oct;36(10):1447-60 16854249
Cites Hum Mol Genet. 2007 Jan 1;16(1):24-35 17158188
Cites Drug Alcohol Depend. 2007 Jun 15;89(1):34-41 17169504
Cites Arch Gen Psychiatry. 2008 Jun;65(6):713-21 18519829
Cites Neuroscience. 2008 Mar 3;152(1):265-72 18082330
Cites Addiction. 2008 Oct;103(10):1678-86 18705688
Cites ACS Chem Neurosci. 2012 May 16;3(5):369-78 22860205
Cites Arch Gen Psychiatry. 2012 Jul;69(7):732-40 22393204
Cites Neuropharmacology. 2013 Jan;64:389-95 22687521
Cites Neuropharmacology. 2013 Jan;64:396-402 22796109
Cites Curr Opin Neurobiol. 2013 Feb;23(1):57-61 22878161
Cites Am J Med Genet B Neuropsychiatr Genet. 2013 Mar;162B(2):224-6 23255320
Cites JAMA Psychiatry. 2013 Mar;70(3):325-33 23303482
Cites Brief Bioinform. 2013 Mar;14(2):251-60 22611119
Cites Neuropsychopharmacology. 2013 May;38(6):1039-49 23303065
Cites Nat Methods. 2013 May;10(5):375-6 23629413
Cites Mol Psychiatry. 2013 Jul;18(7):813-23 22688188
Cites Neuroscience. 2013 Sep 26;249:154-61 23131711
Cites Neuroscience. 2013 Sep 26;249:106-14 23200786
Cites Neuroscience. 2013 Dec 3;253:444-54 24035826
Cites Biol Psychiatry. 2014 Jan 1;75(1):18-24 24135711
Cites Trends Pharmacol Sci. 2013 Nov;34(11):637-44 24325918
Cites Drug Alcohol Depend. 2014 Jan 1;134:362-9 24315570
Cites Addict Biol. 2014 Jan;19(1):111-21 22500942
Cites Compr Psychiatry. 2014 Apr;55(3):621-30 24387979
Cites Int J Public Health. 2014 Apr;59(2):359-72 24122075
Cites Child Abuse Negl. 2014 May;38(5):962-72 24268374
Cites Eur J Pharmacol. 2014 Aug 15;737:97-105 24858366
Cites Addict Biol. 2015 Jan;20(1):205-14 24164917
Cites Hum Immunol. 2015 Jan;76(1):42-51 25500252
Cites Br J Pharmacol. 2015 Feb;172(3):869-82 25258021
Cites Addict Biol. 2015 Mar;20(2):357-67 24373053
Cites Alcohol Clin Exp Res. 2000 Jul;24(7):933-45 10923994
Cites Arch Gen Psychiatry. 2000 Oct;57(10):953-9 11015813
Cites Mol Psychiatry. 2009 Aug;14(8):746-54 19455150
Cites Neuropsychopharmacology. 2009 Aug;34(9):2072-80 19322169
Cites Nature. 2009 Aug 6;460(7256):748-52 19571811
Cites Brief Funct Genomic Proteomic. 2009 May;8(3):194-8 19734301
Cites Drug Alcohol Depend. 2009 Nov 1;105(1-2):139-53 19656642
Cites Lancet. 2009 Oct 17;374(9698):1383-91 19837255
Cites Neuropsychopharmacology. 2009 Dec;34(13):2699-709 19675536
Cites Neuropsychopharmacology. 2009 Dec;34(13):2733-45 19710634
Cites Biochem Soc Trans. 2009 Dec;37(Pt 6):1276-7 19909261
Cites Nat Rev Genet. 2009 Dec;10(12):872-8 19859063
Cites CNS Neurol Disord Drug Targets. 2009 Dec;8(6):451-8 19839936
Cites Neuropsychopharmacology. 2010 Jan;35(1):217-38 19710631
Cites Neuropsychopharmacology. 2010 Mar;35(4):967-75 20010552
Cites Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5082-7 20202923
Cites Addiction. 2010 Mar;105(3):417-30 20402985
Cites Neuroscience. 2010 Jun 30;168(2):371-86 20394803
Cites Proc Natl Acad Sci U S A. 2010 May 18;107(20):9406-11 20439721
Cites Lancet. 2012 Jan 7;379(9810):55-70 22225671
Cites Neuroscience. 2012 Mar 1;204:38-52 21884761
Cites Alcohol. 2012 May;46(3):185-204 22459871
Cites Addict Biol. 2012 May;17(3):687-90 21507154
Cites Am J Psychiatry. 2012 May;169(5):515-22 22407082
Cites Trends Genet. 2012 Jul;28(7):323-32 22480918
Cites Transl Psychiatry. 2012;2:e140 22806211
Cites Pharmacogenomics J. 2012 Aug;12(4):342-8 21468025
Cites Am J Hum Genet. 2007 Sep;81(3):559-75 17701901
Cites Neuropharmacology. 2008 Jan;54(1):108-16 17675104
Cites Arch Gen Psychiatry. 2008 Jan;65(1):53-61 18180429
Cites Soc Cogn Affect Neurosci. 2015 Apr;10(4):501-7 24847112
Cites Nature. 2015 Apr 9;520(7546):224-9 25607358
Cites Perspect Psychol Sci. 2015 Jan;10(1):37-59 25620996
Cites Nat Biotechnol. 2015 Apr;33(4):345-6 25690851
Cites J Neuroimmune Pharmacol. 2015 Jun;10(2):293-301 25796592
Cites Psychol Med. 2015 Sep;45(12):2605-17 25853627
Cites Prog Neuropsychopharmacol Biol Psychiatry. 2010 Jun 30;34(5):791-7 19903506
Cites Am J Hum Genet. 2010 Jul 9;87(1):139-45 20598278
GRANTS
GRANTID AGENCY COUNTRY
DA031579 NIDA NIH HHS United States
DA033369 NIDA NIH HHS United States
HHSN268200782096C PHS HHS United States
K02 DA032573 NIDA NIH HHS United States
K02DA32573 NIDA NIH HHS United States
N01-HG-65403 NHGRI NIH HHS United States
P01 CA089392 NCI NIH HHS United States
R01 AG045231 NIA NIH HHS United States
R01 DA013423 NIDA NIH HHS United States
R01 DA019963 NIDA NIH HHS United States
R01 DA023668 NIDA NIH HHS United States
R01 DA031579 NIDA NIH HHS United States
R01 DA033369 NIDA NIH HHS United States
R01 DA17305 NIDA NIH HHS United States
R01 ES024992 NIEHS NIH HHS United States
R01 HG007175 NHGRI NIH HHS United States
R01 HG007354 NHGRI NIH HHS United States
R01-AG045231 NIA NIH HHS United States
R01DA23668 NIDA NIH HHS United States
R01ES024992 NIEHS NIH HHS United States
R01HG007175 NHGRI NIH HHS United States
R01HG007354 NHGRI NIH HHS United States
U01 HG004422 NHGRI NIH HHS United States
U01 HG004446 NHGRI NIH HHS United States
U01HG004438 NHGRI NIH HHS United States
U10 AA008401 NIAAA NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's
OTHERID SOURCE
NIHMS707060 [Available on 11/01/16] NLM
PMC4700831 [Available on 11/01/16] NLM